CIMAVAX-EGF and Racotumomab for the treatment of Lung Cancer

submitted by citiliner on 04/02/16 1

CIMAVAX-EGF and Racotumomab are the first worldwide registered therapeutic vaccines for non-small lung cancer developed in Cuba by the Center for Molecular Immunology in conjunction with the Center for Genetic Engineering and Biotechnology. The vaccines are based on active immunotherapy which is the process of using the body’s immune system to fight cancer. Both vaccines are well tolerated and have fewer side effects than the standard cancer treatments increasing patients’ life expectancy and improving quality of life. At Cubaheal, we know how difficult it is sometimes to reach the right people and the right treatment. We work closely with healthcare providers, the Ministry of Health, and government officials in the Republic of Cuba to provide the highest quality healthcare at the most reasonable prices. At Cubaheal we have dedicated our services to making sure that your treatment in Cuba is as hassle free and as straightforward as possible. Cubaheal will be responsible for the arrangement of all the logistics regarding your visit to Cuba while seeking treatment. That includes, transportation, treatment reservation, hotel and accommodation planning, and meal plans for you and a companion should you wish to. www.cubaheal.com/ sales@cubaheal.com

Leave a comment

Be the first to comment

Email
Message
×
Embed video on a website or blog
Width
px
Height
px
×
Join Huzzaz
Start collecting all your favorite videos
×
Log in
Join Huzzaz

facebook login
×
Retrieve username and password
Name
Enter your email address to retrieve your username and password
(Check your spam folder if you don't find it in your inbox)

×